PATENT CLAIM ANALYSIS

Application Number: 15938956
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["514", "616000"]

Abstract:
Methods of administering and pharmaceutical compositions of a biphenyl sulfonamide compound which is a dual angiotensin and endothelin receptor antagonist are disclosed for treating diseases.

Claim (Index 44):
The method according to  claim 36 , wherein the chronic inflammatory disease is rheumatoid arthritis.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 90.0
- Lexical Diversity: 1.13043
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15687407', '14631768', '12937630', '14795123', '12267321']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7453727157555018
- 35 USC 102 Novelty (BERT): 0.5404122075527141
- Combined Prediction Score: 0.7248766649352231
- Mean Citation Score: 263.82115600000003
- Max Citation Score: 352.77805
- Similarity Product: 215.83848975480493

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test